论文部分内容阅读
为明确对Ⅰ、Ⅱ期中、高度恶性非何杰金淋巴瘤(NHL)的治疗是单纯化疗还是化疗放疗联合应用效果更好,作者研究401例病人,均为新诊断的Ⅰ、Ⅱ期NHL。分为化疗组201例,年龄≤60岁103例,>60岁98例,Ⅰ期135例,Ⅱ期66例;乳酸脱氢酶(LDH)正常159例,增高42例,体能状态0或1级193例,2级8例;危险因素(即年龄>60岁、分期、LDH、体能状态)无或1项142例,2项44例,3项14
To clarify that the treatment of stage I, II, and high-grade non-Hodgkin lymphoma (NHL) is a combination of chemotherapy alone or chemotherapy, the authors studied 401 patients, all newly diagnosed stage I and II NHL. 201 patients were divided into chemotherapy group, 103 patients aged 60 years or older, 98 patients> 60 years old, 135 patients in stage I, 66 patients in stage II, 159 lactate dehydrogenase (LDH) normal, 42 cases increased, and physical status 0 or 1 Grade 193 cases, Grade 2 8 cases; Risk factors (ie, age> 60 years, staging, LDH, physical status) None or 1 item 142 cases, 2 items 44 cases, 3 items 14